ReviewJournal of hepatocellular carcinoma2020

Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations.

Audrey Debaillon Vesque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.